ScripArcturus Therapeutics and licensing partner CSL have got approval in the EU for Kostaive, a self-amplifying mRNA (sa-mRNA) vaccine that the firms hope will become a major product in the COVID-19 space
Pink SheetA self-amplifying mRNA vaccine for COVID-19, Arcturus Therapeutics’ Kostaive (ARCT-154), has been the subject of extensive disparaging and scientifically inaccurate comments online in its first market
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck KGaA Pays $600m For Transfection
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. SNBL To Pay 28% Premium To Re-Acquire S